2 results
Approved WMOWill not start
To assess the safety and tolerability profile of durvalumab monotherapy, durvalumab + novel oncology therapy, durvalumab + chemotherapy, anddurvalumab + novel oncology therapy + chemotherapy combinations
Approved WMOCompleted
The aim of this study is to validate a clinical VLE prediction score and to develop a VLE computer algorith that could improve detection of early neoplasie in BE patients.